Get the Stockscreener App
0.00
100.00%
-42.98
After Hours:
42.99
42.99
+
Surmodics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
See More
Previous Close:
$42.98
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$614.51M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
0.00
EPS:
0.38
Net Cash Flow:
$9.86M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$43.00
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
0.00 | 614.51M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
125.08 | 218.05B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.52 | 144.86B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.02 | 139.34B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.36 | 130.75B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.19 | 49.78B | 5.88B | 1.34B | 799.60M | 2.3489 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-25 | Downgrade | Barrington Research | Mkt Perform → Underperform |
| Mar-07-25 | Upgrade | Lake Street | Hold → Buy |
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
How interest rate cuts could boost Surmodics Inc. stockJuly 2025 Levels & Precise Buy Zone Identification - Newser
How sustainable is Surmodics Inc. stock dividend payoutTreasury Yields & Stepwise Trade Signal Guides - Newser
Understanding Momentum Shifts in (SRDX) - news.stocktradersdaily.com
GTCR/Surmodics Win On Divestiture, Share Analysis And Captive Capacity - MarketScreener
SurModics, Inc. Financial Disclosures & Filings - TradingView
[EFFECT] SURMODICS INC SEC Filing - Stock Titan
Is Surmodics Inc. stock a safe investment in uncertain marketsWeekly Trade Analysis & Accurate Technical Buy Alerts - newser.com
Will Surmodics Inc. stock recover faster than marketWeekly Trade Review & Risk Managed Investment Entry Signals - newser.com
Is Surmodics Inc. stock positioned well for digital economy2025 Big Picture & Safe Entry Zone Identification - newser.com
Surmodics, Inc.(NasdaqGS:SRDX) dropped from S&P Healthcare Equipment Select Industry Index - MarketScreener
Surmodics, Inc.(NasdaqGS: SRDX) dropped from S&P Global BMI Index - MarketScreener
Surmodics, Inc.(NasdaqGS: SRDX) dropped from S&P TMI Index - MarketScreener
Nashville InnoSurmodics adds to med-device portfolio with $39.9M acquisition of Vetex Medical - The Business Journals
Trade Surmodics IncSRDX CFD - Capital.com
Surmodics Inc share price - Capital.com
Will Surmodics Inc. stock gain from strong economyWeekly Investment Recap & Weekly Breakout Stock Alerts - newser.com
What earnings revisions data tells us about Surmodics Inc.Portfolio Risk Summary & Real-Time Market Sentiment Reports - newser.com
Surmodics, Inc. Hits New 52-Week High at $42.89 - Markets Mojo
How to interpret RSI for Surmodics Inc. stockEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
[Form 4] SURMODICS INC Insider Trading Activity - Stock Titan
[POS AM] SURMODICS INC SEC Filing - Stock Titan
Surmodics, Inc. Announces CEO Changes, Effective as of November 19, 2025 - MarketScreener
Key metrics from Surmodics Inc.’s quarterly data2025 Price Targets & Free Verified High Yield Trade Plans - newser.com
Should you wait for a breakout in Surmodics Inc.Market Activity Summary & Daily Technical Stock Forecast Reports - newser.com
Will Surmodics Inc. stock outperform tech sector in 2025July 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
Surmodics Stock Surges 63%, With A 8-Day Winning Spree - Trefis
Surmodics (NASDAQ:SRDX) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.78%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):